These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5908852)

  • 1. Protective activity of normal chicken serum in Klebsiella pneumoniae infection.
    Picoff ER
    J Infect Dis; 1966 Feb; 116(1):27-32. PubMed ID: 5908852
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective and serologically active fractions from phenol extract of Mycobacterium tuberculosis.
    Hedgecock LW
    Am Rev Respir Dis; 1965 Dec; 92(6):973-8. PubMed ID: 4954270
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the low resistance period in determining the effective dosage of chlortetracycline in mice. Immunological investigations in experimental chemotherapy. IV.
    Sackmann W
    Chemotherapy; 1971; 16(3):196-202. PubMed ID: 4397819
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum resistance properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources.
    Podschun R; Teske E; Ullmann U
    Zentralbl Hyg Umweltmed; 1991 Nov; 192(3):279-85. PubMed ID: 1777008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
    Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
    Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
    Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
    Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of human serum against strains of Klebsiella from different sources.
    Benge GR
    J Med Microbiol; 1988 Sep; 27(1):11-5. PubMed ID: 3050105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.
    Yother J; Volanakis JE; Briles DE
    J Immunol; 1982 May; 128(5):2374-6. PubMed ID: 7061864
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serum concentration of bactericidal antibiotics (rifampicin, cephaloridine) in relation to the low resistance period in experimental infections. Immunological investigations in experimental chemotherapy. V.
    Sackmann W
    Chemotherapy; 1971; 16(3):203-10. PubMed ID: 4397820
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.
    Kerr AR; Wei XQ; Andrew PW; Mitchell TJ
    Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.
    Briles DE; Nahm M; Schroer K; Davie J; Baker P; Kearney J; Barletta R
    J Exp Med; 1981 Mar; 153(3):694-705. PubMed ID: 7252411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.
    Choi EH; Zhang F; Lu YJ; Malley R
    Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of increased antibody responses to pneumococcal type 19F polysaccharide by Klebsiella polysaccharide.
    Lee CJ; Wang Z
    J Infect Dis; 1985 Apr; 151(4):658-64. PubMed ID: 3973415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice.
    Hetland G; Ohno N; Aaberge IS; Lovik M
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):111-6. PubMed ID: 10640605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigens common to human and bacterial cells. IV. Studies of human pneumococcal disease.
    Reed WP; Drach GW; Williams RC
    J Lab Clin Med; 1974 Apr; 83(4):599-610. PubMed ID: 4131779
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the characteristics of 390 strains belonging to the genus Klebsiella. Their behavior on media with brilliant green].
    Baron G; Beerens H
    Ann Inst Pasteur Lille; 1971; 22():101-20. PubMed ID: 4949947
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media.
    Simell B; Jaakkola T; Lahdenkari M; Briles D; Hollingshead S; Kilpi TM; Käyhty H
    Clin Vaccine Immunol; 2006 Oct; 13(10):1177-9. PubMed ID: 16928889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cells Are Activated by
    Fritscher J; Amberger D; Dyckhoff S; Bewersdorf JP; Masouris I; Voelk S; Hammerschmidt S; Schmetzer HM; Klein M; Pfister HW; Koedel U
    Front Immunol; 2018; 9():550. PubMed ID: 29616039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood clearance of Streptococcus pneumoniae by C-reactive protein.
    Horowitz J; Volanakis JE; Briles DE
    J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.